Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Lisicki Robert | 0001779614 | Jul-23-2023 | director |
MURPHY JOHN RAYMOND | 0001275195 | Jan-19-2023 | director |
Szot Matthew K | 0001401385 | Jan-19-2023 | officer: Chief Financial Officer |
Pham Quang X | 0001405290 | Jan-19-2023 | director, 10 percent owner, officer: CEO and Chairman |
WILSON GLYNN | 0001405625 | Jan-19-2023 | director |
Zelenkofske Steven | 0001578333 | Jan-19-2023 | director |
LOSORDO DOUGLAS W | 0001583810 | Jan-19-2023 | officer: Chief Medical Officer |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Cadrenal Therapeutics, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-031923 ( Act) Size: 5 KB |
Apr-10-2024 | |
8-K | Document | Current report filing Acc-no: 0001213900-24-031371 (34 Act) Size: 213 KB |
Apr-09-2024 | 24831382 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-029930 ( Act) Size: 5 KB |
Apr-03-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0001213900-24-029925 ( Act) Size: 12 KB |
Apr-03-2024 | |
EFFECT | Document | Acc-no: 9999999995-24-000826 (33 Act) Size: 1 KB | Apr-02-2024 | 24816753 |
POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001213900-24-028970 (33 Act) Size: 241 KB |
Apr-02-2024 | 24811446 |
EFFECT | Document | Acc-no: 9999999995-24-000694 (33 Act) Size: 1 KB | Mar-20-2024 | 24769291 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001213900-24-023386 ( Act) Size: 27 KB |
Mar-18-2024 | |
UPLOAD | Document | Acc-no: 0000000000-24-002871 ( Act) Size: 39 KB | Mar-15-2024 | |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001213900-24-021594 (33 Act) Size: 64 KB |
Mar-12-2024 | 24740321 |
S-3 | Document | Registration statement for specified transactions by certain issuers Acc-no: 0001213900-24-021580 (33 Act) Size: 918 KB |
Mar-12-2024 | 24740254 |
8-K | Document | Current report filing Acc-no: 0001213900-24-021512 (34 Act) Size: 452 KB |
Mar-12-2024 | 24739429 |
8-K | Document | Current report filing Acc-no: 0001213900-24-021251 (34 Act) Size: 231 KB |
Mar-11-2024 | 24736741 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-24-021133 (34 Act) Size: 7279 KB |
Mar-11-2024 | 24735851 |
8-K | Document | Current report filing Acc-no: 0001213900-24-020181 (34 Act) Size: 198 KB |
Mar-05-2024 | 24722448 |
8-K/A | Document | Amendment to Current report filing Acc-no: 0001213900-24-014316 (34 Act) Size: 203 KB |
Feb-15-2024 | 24642167 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-24-001336 (34 Act) Size: 88 KB |
Feb-14-2024 | 24636889 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001213900-24-013432 (34 Act) Size: 108 KB |
Feb-13-2024 | 24630034 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001213900-24-012839 (34 Act) Size: 85 KB |
Feb-12-2024 | 24622354 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-012837 ( Act) Size: 5 KB |
Feb-12-2024 |
Recent 20 filings. View all Cadrenal Therapeutics, Inc. filings
Thanks I look forward to using the product to improve my skin tone
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by